Oxford Nanopore Technologies Ltd develops nanopore-based electronic systems for analyzing single molecules, including DNA, RNA, and proteins.In January 2023, Oxford Nanopore Technologies Ltd issued 384,471 ordinary shares of £0.0001 each under the company's share option plans and the issuance of shares under certain of the company's remuneration schemes.In January 2022, Oxford Nanopore Technologies Ltd expected to report core Life Science Research Tools (LSRT) of above £120 million, compared to LSRT revenue of £65.5 million in FY20, representing an annual growth in excess of 83%. The company expected to report total revenue of above £126 million, compared to the total revenue of £113.9 million in FY20